# Northwest Biotherapeutics Inc: Form 8-K, filed Jan 13, 2023

- Company: [Northwest Biotherapeutics Inc](/companies/nwbo.md) (CIK 1072379)
- Form: 8-K
- Filed: 2023-01-13
- Accepted by EDGAR: Jan 13, 2023, 16:34 ET
- Period: 2023-01-09
- Accession: 0001104659-23-003846
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1072379/000110465923003846/tm233422d1_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1072379/000110465923003846/

## Items reported

- Item 5.03: Amendment to articles or bylaws
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1072379/000110465923003846/tm233422d1_8k.htm

Filed Jan 13, 2023.
Source: SEC EDGAR, the filing index for accession 0001104659-23-003846. Last ingested by Listed: Nov 14, 2026, 21:35 ET. No prices; not investment advice.
